VR Logo

Jagsonpal Pharmaceuticals: Statement Of Investor Complaints For The Quarter Ended September 2021


No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0000
Name of the Signatory :- NANDITA SINGH
Designation :- Company Secretary and Compliance Officer